What is Fuan Pharmaceutical (Group) Co., Ltd.'s (300194.SZ) StockRank?

MoatMap's StockRank for Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) is 43/100, with a Hold signal. This is a composite score combining Quality (52), Value (44), and Momentum (38) factor ranks across MoatMap's 20,000+ stock universe.

Does Fuan Pharmaceutical (Group) Co., Ltd. have an economic moat?

Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Fuan Pharmaceutical (Group) Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Fuan Pharmaceutical (Group) Co., Ltd. in?

Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300194.SZ

HOLDREMOVE

Fuan Pharmaceutical (Group) Co., Ltd. · Healthcare · China · $672M · Avg Vol: $5M/d

StockRank

P/E (TTM)

72.2x

ROE

1.4%

D/E

0.1x

Dividend %

1.9%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Fuan Pharmaceutical is a Chinese generic drug manufacturer. It faces intense margin pressure from China's volume-based procurement (VBP) program, failing our Terry Smith lens due to a lack of pricing power and low ROIC.

COMPANY DESCRIPTION

Fuan Pharmaceutical (Group) Co., Ltd. is a vertically integrated pharmaceutical company specializing in the research, production, and sale of chemical APIs (Active Pharmaceutical Ingredients) and finished dosages. The company's product portfolio focuses on anti-infectives, oncology, and respiratory therapies. Its competitive moat is sustained by its cost-efficient, vertically integrated manufacturing model, which ensures regulatory compliance and stable supply chains from raw materials to finished formulations.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	358M	391M	353M	257M	-10.5%
EPS	0.03	0.03	0.04	0.01	-29.3%
Shares	1.2B	1.2B	1.2B	1.2B	0.0%
Debt	106M	132M	104M	118M	3.9%
Equity	583M	613M	650M	645M	3.4%
Op CF	50M	49M	45M	46M	-2.7%
Inv CF	-65M	-14M	-39M	-33M	—
Fin CF	-25M	7M	-34M	-1M	—

PRICE (1M)-13.7%

SMA 50SMA 200

$0.53

RSI (14)

35.6

52W High

$0.80

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

2.1%48.8

ROE

1.4%47.4

GP/Assets

10.1%25.9

Op. Margin

8.7%63.2

FCF/Assets

3.6%64.1

Piotroski

—83.5

Int. Cover

4.8x54.1

D/E Ratio

0.15x59.0

Current Ratio

2.25x42.0

Value

P/E (TTM)

72.2x13.5

EV/EBITDA

15.9x25.3

P/FCF

150.3x54.9

P/B

1.0x79.6

P/S

2.6x60.8

Div Yield

1.9%49.5

Momentum

52W High %

66%51.2

RS 6M

-30%41.6

SMA 50/200

0.92x39.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-21%24.1

FUNDAMENTALS

Market Cap

$672M

P/E (Forward)

9.5x

Gross Margin

34.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300194.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300194.SZ	Fuan Pharmaceutical (Group) Co., Ltd.(you)	$672M	43	HOLD
600829.SS	HPGC Renmintongtai Pharmaceutical Corporation	$746M	46	HOLD
002688.SZ	Jinhe Biotechnology CO., LTD.	$628M	39	HOLD
688117.SS	ChengDu ShengNuo Biotec Co.,Ltd.	$785M	48	HOLD
600488.SS	Tianjin Tianyao Pharmaceuticals Co., Ltd.	$894M	40	HOLD
000813.SZ	Dezhan Healthcare Company Limited	$1.0B	42	HOLD
300158.SZ	Shanxi Zhendong Pharmaceutical Co.,Ltd	$738M	34	SELL
002728.SZ	Teyi Pharmaceutical Group Co.,Ltd	$671M	32	SELL
301277.SZ	Newland Pharmaceutical Co., Ltd.	$574M	34	SELL
002793.SZ	Luoxin Pharmaceuticals Group Stock Co., Ltd.	$690M	31	SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) — Stock Score Summary

Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) has a MoatMap StockRank of 43/100 based on Quality (52/100), Value (44/100), and Momentum (38/100) factor scores. The current signal is HOLD. Fuan Pharmaceutical is a Chinese generic drug manufacturer. It faces intense margin pressure from China's volume-based procurement (VBP) program, failing our Terry Smith lens due to a lack of pricing power and low ROIC.

Key Financial Metrics

Price	$0.53
Market Cap	$672M
P/E (TTM)	72.20
P/E (Forward)	9.50
Price/Book	0.97
Return on Equity	1.4%
Return on Invested Capital	2.1%
Debt/Equity	14.63
Gross Margin	34.7%
Operating Margin	8.7%
Revenue Growth	-12.9%
Dividend Yield	1.9%
Free Cash Flow	$4M

Fuan Pharmaceutical (Group) Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Fuan Pharmaceutical (Group) Co., Ltd.’s (300194.SZ) StockRank?: MoatMap’s StockRank for Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) is 43/100, with a Hold signal. It is a composite of Quality (52), Value (44), and Momentum (38) factor ranks across MoatMap’s 20,000+ stock universe.
Does Fuan Pharmaceutical (Group) Co., Ltd. have an economic moat?: Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Fuan Pharmaceutical (Group) Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Fuan Pharmaceutical (Group) Co., Ltd. in?: Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).